Elisabet Londos
41 – 50 of 149
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2016
-
Mark
Associations between TOMM40 Poly-T Repeat Variants and Dementia in Cases with Parkinsonism.
(
- Contribution to journal › Article
-
Mark
Cholinesterase inhibitor therapy does not affect time spent in nursing homes in patients with Alzheimer’s disease.
2016) Alzheimer’s Association International Conference 2016(
- Contribution to conference › Poster
-
Mark
Cholinesterase inhibitors do not alter the length of stay in nursing homes among patients with Alzheimer's disease : A prospective, observational study of factors affecting survival time from admission to death.
(
- Contribution to journal › Article
-
Mark
Cerebrospinal fluid Alzheimer's disease biomarkers across the spectrum of lewy body diseases : Results from a large multicenter cohort
(
- Contribution to journal › Article
-
Mark
Prevalence of Dementia With Lewy Body Symptoms : A Cross-Sectional Study in 40 Swedish Nursing Homes
(
- Contribution to journal › Article
-
Mark
Reliability, validity and clinical correlates of the Quality of Life in Alzheimer's disease (QoL-AD) scale in medical inpatients
(
- Contribution to journal › Article
-
Mark
Alzheimer's disease cerebrospinal fluid biomarkers predict cognitive decline in lewy body dementia
(
- Contribution to journal › Article
- 2015
-
Mark
Cerebrospinal fluid levels of IL-6 are decreased and correlate with cognitive status in DLB patients.
(
- Contribution to journal › Article
-
Mark
Longitudinal Associations between Survival in Alzheimer's Disease and Cholinesterase Inhibitor Use, Progression, and Community-Based Services.
(
- Contribution to journal › Article
-
Mark
Lack of orthostatic symptoms in dementia patients with orthostatic hypotension.
(
- Contribution to journal › Article